References
- Maruna P., Nedelnikova K., Gürlich R. Physiology and genetics of procalcitonin. Physiol Res 2000; 49(Suppl 1)s57–61
- Meisner M. Pathobiochemistry and clinical use of procalcitonin. Clin Chim Acta 2002; 323: 17–29
- Oczenski W., Fitzgerald R. D., Schwarz S. Procalcitonin: a new parameter for the diagnosis of bacterial infection in the peri‐operative period. Eur J Anaesthesiol 1998; 15: 202–9
- Russwurm S., Wiederhold M., Oberhoffer M., Stonans I., Zipfel P. F., Reinhart K. Molecular aspects and natural source of procalcitonin. Clin Chem Lab Med 1999; 37: 789–97
- Whicher J., Bienvenu J., Monneret G. Procalcitonin as an acute phase marker. Ann Clin Biochem 2001; 38: 483–93
- Reinhart K., Karzai W., Meisner M. Procalcitonin as a marker of the systemic inflammatory response to infection. Intensive Care Med 2000; 26: 1193–200
- Gendrel D., Bohuon C. Procalcitonin as a marker of bacterial infection. Pediatr Infec Dis J 2000; 19: 679–88
- Whiting P., Rutjes A. W. S., Reitsma J. B., Bossuyt P. M. M., Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003; 3: 25
- Aouifi A., Piriou V., Bastien O., Blanc P., Bouvier H., Evans R. Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients. Crit Care Med 2000; 28: 3171–6
- Meisner M., Rauschmayer C., Schmidt J., Feyrer R., Cesnjevar R., Bredle D. Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complications. Intensive Care Med 2002; 28: 1094–102
- Adamik B., Kielb J. K., Golebiowska B., Gamian A., Kübler A. Effect of sepsis and cardiac surgery with cardiopulmonary bypass on plasma level of nitric oxide metabolites, neopterin and procalcitonin: correlation with mortality and postoperative complications. Intensive Care Med 2000; 26: 1259–67
- Rothenburger M., Markewitz A., Lenz T., Kaulbach H. G., Marohl K., Kuhlmann W. Detection of acute phase response and infection. The role of procalcitonin and C‐reactive protein. Clin Chem Lab Med 1999; 37: 275–79
- Meisner M., Tschaikowski K., Hutzler A., Schick C., Schüttler J. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 1998; 24: 680–4
- Hensel M., Volk T., Döcke W. D., Kern F., Tschirna D., Egerer K. Hyperprocalcitonemia in patients with non‐infectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass. Anesthesiology 1998; 89: 93–104
- Dörge H., Schöndube F. A., Dörge P., Seipelt R., Voss M., Messmer B. J. Procalcitonin is a valuable prognostic marker in cardiac surgery but not specific for infection. Thorac Cardiov Surg 2003; 51: 322–6
- Reith B. H., Mittelkötter U., Debus E. S., Küssner C., Thiede A. Procalcitonin in early detection of postoperative complications. Dig Surg 1998; 15: 260–5
- Di Filippo A., Lombardi A., Ognibene A., Messeri G., Tonelli F. Procalcitonin as an early marker of postoperative infectious complications. Minerva Chir 2002; 57: 59–62
- Reid M. C., Lachs M. S., Feinstein A. R. Use of methodological standards in diagnostic test research. JAMA 1999; 274: 645–51
- Lumbrenes‐Lacarra B., Ramos‐Rincón J. M., Hernández‐Aguado I. Methodology in diagnostic laboratory test research in clinical chemistry and clinical chemistry and laboratory medicine. Clin Chem 2004; 50: 530–6